Product Information
KESIMPTA 20 MG/0.4 ML PEN is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $24380.2266 per ML under NDC 00078100768. Its NADAC has been published 123 times since Apr 17, 2024.
Strength
20 mg/.4mL
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078100768
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
OFATUMUMABApproval Type
Biologic (BLA)
FDA Application
BLA125326On Market Since
10/26/2009
Pharmacological Classes
Price Statistics
The NADAC for KESIMPTA 20 MG/0.4 ML PEN has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 15.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $24380.2266 per ML |
|---|---|
| All-time high | $24459.3201 (May 13, 2026) |
| All-time low | $21064.8423 (Jul 17, 2024) |
| 52-week high | $24459.3201 |
| 52-week low | $22578.6032 |
| Median price | $22601.0045 |
| Average price | $22597.1832 |
| Largest weekly change | +8.0% (Jan 14, 2026) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ofatumumab market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of KESIMPTA 20 MG/0.4 ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for KESIMPTA 20 MG/0.4 ML PEN, manufactured by Novartis Pharmaceuticals Corporation, is $24380.2266 per ML (NDC 00078100768), effective Aug 19, 2026.
How has the price of KESIMPTA 20 MG/0.4 ML PEN changed over time?
Over the history we have for it, the NADAC for KESIMPTA 20 MG/0.4 ML PEN has risen 15.7%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for KESIMPTA 20 MG/0.4 ML PEN?
Since Apr 17, 2024, the NADAC for KESIMPTA 20 MG/0.4 ML PEN has ranged from a low of $21064.8423 (Jul 17, 2024) to a high of $24459.3201 (May 13, 2026), with a median of $22601.0045 per ML.
Are there cheaper alternatives to KESIMPTA 20 MG/0.4 ML PEN?
No other NADAC-published product currently shares the active ingredient and strength of KESIMPTA 20 MG/0.4 ML PEN in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures KESIMPTA 20 MG/0.4 ML PEN?
KESIMPTA 20 MG/0.4 ML PEN (NDC 00078100768) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.